Clinical Trials for All Types of Brain Metastases, Including Breast Cancer

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases

A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic
Radiosurgery (SRS)

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Tumor Bed Hypofractionated IMRT After Surgery for Patients With Single,Large Brain Metastases From Solid Tumor

Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases
(RAD 1502/UAB 1593)

Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases

Palbociclib In Progressive Brain Metastases

Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases

Stereotactic Radiosurgery (SRS) for Brain Metastasis

A Proof-of-principle Study of Hyperbaric Oxygen as a Radiosensitizer Prior to Stereotactic Radiosurgery for Brain Metastases

Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases

Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis

Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases

Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

Local Radiotherapy Following Complete Resection of a Brain Metastasis

Whole Brain Radiation Using IMRT for Patients With Brain Metastases

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

Pembrolizumab In Central Nervous System Metastases

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)

Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases

Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)

Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases

Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)

Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial

Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

Fractionated Stereotactic Radiosurgery for Large Brain Metastases

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression?

Minocycline Therapy for Management of Adverse Radiation Effects

A Prospective Phase III Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.

FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions

Observation for Patients With Asymptomatic CNS Metastatic Disease

Assessment of Eloquent Function in Brain Tumor Patients

Safety Study of Afatinib for Brain Cancer

Using Electrocorticogram (ECoG) in Predicting Eloquent Cortex and Post-Op Functional Outcomes in Patients With Brain Tumors

MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning